Josh Major, Kurt Mahnken, Merhawit Ghebrehiwet, Payton Clark, Josh Autaubo, Andrew Wilson, Jake Checketts, Alicia Ford, Matt Vassar
{"title":"Recruitment and Retention Strategies in Clinical Trials for Hip Fractures: A Cross-Sectional Analysis.","authors":"Josh Major, Kurt Mahnken, Merhawit Ghebrehiwet, Payton Clark, Josh Autaubo, Andrew Wilson, Jake Checketts, Alicia Ford, Matt Vassar","doi":"10.5435/JAAOSGlobal-D-24-00242","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To investigate the recruitment and retention strategies in clinical trials evaluating hip fractures, with a focus on underrepresented populations.</p><p><strong>Background: </strong>The prevalence and burden of hip fractures necessitate diverse and representative clinical trials to improve management outcomes. Underrepresented populations often face barriers to participation, affecting the generalizability of trial results.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis of clinical trials on hip fractures published between 2018 and 2023. We searched Embase and MEDLINE, screening and extracting data in a masked duplicate manner. For statistical analysis, Stata 18 SE (StataCorp LLC) was used to determine frequencies of recruitment and retention strategies.</p><p><strong>Results: </strong>We screened 624 studies, with 72 meeting our inclusion criteria. Trials were conducted in the United States (12/72, 16.7%), non-United States (53/72, 73.6%), or both (7/72, 9.7%). Only one trial (1.4%) mentioned specific recruitment strategies, and three (4.2%) reported measures to minimize participant dropout. Overall, the mention of strategies for diverse participation was scarce.</p><p><strong>Conclusion: </strong>There is a notable lack of recruitment and retention strategies directed at promoting diverse participation in hip fracture trials. This study highlights the need for improved inclusiveness and equity in future clinical trials to enhance the generalizability of their findings and better serve all populations affected by hip fractures.</p>","PeriodicalId":45062,"journal":{"name":"Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews","volume":"9 5","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043341/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Academy of Orthopaedic Surgeons Global Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5435/JAAOSGlobal-D-24-00242","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To investigate the recruitment and retention strategies in clinical trials evaluating hip fractures, with a focus on underrepresented populations.
Background: The prevalence and burden of hip fractures necessitate diverse and representative clinical trials to improve management outcomes. Underrepresented populations often face barriers to participation, affecting the generalizability of trial results.
Methods: We conducted a cross-sectional analysis of clinical trials on hip fractures published between 2018 and 2023. We searched Embase and MEDLINE, screening and extracting data in a masked duplicate manner. For statistical analysis, Stata 18 SE (StataCorp LLC) was used to determine frequencies of recruitment and retention strategies.
Results: We screened 624 studies, with 72 meeting our inclusion criteria. Trials were conducted in the United States (12/72, 16.7%), non-United States (53/72, 73.6%), or both (7/72, 9.7%). Only one trial (1.4%) mentioned specific recruitment strategies, and three (4.2%) reported measures to minimize participant dropout. Overall, the mention of strategies for diverse participation was scarce.
Conclusion: There is a notable lack of recruitment and retention strategies directed at promoting diverse participation in hip fracture trials. This study highlights the need for improved inclusiveness and equity in future clinical trials to enhance the generalizability of their findings and better serve all populations affected by hip fractures.
目的:探讨评估髋部骨折临床试验的招募和保留策略,重点关注代表性不足的人群。背景:髋部骨折的患病率和负担需要多样化和有代表性的临床试验来改善治疗结果。代表性不足的人群往往面临参与障碍,影响试验结果的普遍性。方法:我们对2018年至2023年发表的髋部骨折临床试验进行了横断面分析。我们搜索Embase和MEDLINE,以屏蔽重复的方式筛选和提取数据。为了进行统计分析,使用Stata 18 SE (StataCorp LLC)来确定招聘和保留策略的频率。结果:我们筛选了624项研究,其中72项符合我们的纳入标准。试验在美国(12/72,16.7%)、非美国(53/72,73.6%)或两者均进行(7/72,9.7%)。只有一项试验(1.4%)提到了具体的招募策略,三项试验(4.2%)报告了减少参与者退出的措施。总的来说,很少提及多样化参与的战略。结论:在髋部骨折试验中,明显缺乏旨在促进多样化参与的招募和保留策略。该研究强调了在未来的临床试验中需要提高包容性和公平性,以增强其研究结果的普遍性,并更好地为所有受髋部骨折影响的人群服务。